Latest brain cancer Stories

Researchers have found no clear link between mobile phones and brain cancer, although researchers did say that further studies are necessary due to increasingly intensive use. "The study doesn't reveal an increased risk, but we can't conclude that there is no risk because there are enough findings that suggest a possible risk," the study's chief author, Elisabeth Cardis, told AFP.The Interphone study results included 2,708 cases of glioma tumors and 2,409 meningioma tumors in 13...

Medical Researchers at the University of Alberta reported today evidence that the orphan generic drug Dichloroacetate (DCA) may hold promise as potential therapy for perhaps the deadliest of all human cancers: a form of brain cancer called glioblastoma. The report was published May 12 in the journal Science Translational Medicine, a journal of the American Association of the Advancement of Science.In 2007 the U of A team led by Dr. Evangelos Michelakis, published evidence that DCA reverses...

Study identifies patients with longer-than-expected survival timesA study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.The research by The Cancer Genome Atlas (TCGA), published online today in the journal Cancer Cell, used...

Brains on Bikes raises funds to 'outsmart brain cancer' SAN FRANCISCO, April 9 /PRNewswire-USNewswire/ -- Anne Feeley, a 55-year-old mother and brain cancer survivor, began a 3,781-mile ride across the country today to raise money and awareness for brain cancer research and support. The effort, called Brains on Bikes, kicked off from the University of California, San Francisco Mission Bay campus following a celebration that included remarks by Dr. Michael Prados, director at the UCSF...

DALLAS, March 8 /PRNewswire/ -- The Beryl Institute, the research and educational arm of The Beryl Companies, will host its third annual Barry Spiegelman Memorial Golf Classic on April 13 at Sky Creek Ranch Golf Club in Keller, Texas to celebrate the life of Beryl co-founder Barry Spiegelman, who lost his battle with brain cancer in September 2005. All proceeds from the tournament will fund brain cancer research at Art of the Brain, UCLA's Neuro-Oncology Program. Barry's brother and...

Brains on Bikes Raises Funds to Improve Mortality Rate that Hasn't Changed in a Decade NEW YORK, Feb. 26 /PRNewswire-USNewswire/ -- Anne Feeley, a 55-year-old mother and brain cancer survivor, will cycle across the country this spring to raise awareness and money for brain cancer research and support. The effort, called Brains on Bikes, will kick off April 9 as Feeley, joined by her friend and trainer Gundula Hennig and dog Walter, will kick off in San Francisco and ride into...

Working with mice, Johns Hopkins scientists who tested drugs intended to halt growth of brain cancer stem cells "“ a small population of cells within tumors that perpetuate cancer growth "“ conclude that blocking these cells may be somewhat effective, but more than one targeted drug attack may be needed to get the job done.One focus of attack is a chemical pathway within stem cells known as Notch, which scientists have shown is important for cancer stem cell growth.  A new study...

TUSTIN, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer.(1) Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able...

BEIJING, Dec. 17 /PRNewswire-Asia/ -- Using a novel stem cell based technology of Cellonis Biotechnologies, Beijing, a Chinese research/medical team may eliminate a glioma -- brain cancer -- of a 36 year old Norwegian patient in a hospital in Beijing. The treatment shows that the activated immune system can directly kill tumor stem cells as well as cancer daughter cells. The amazing outcome of this novel treatment within a Comprehensive Cancer Therapy tells Cellonis that the future...

TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with relapsed glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara is a targeted monoclonal antibody linked to a radioisotope being developed as a potential new treatment for GBM. Cotara specifically targets cells at the center of brain tumors, so its...